Atlas Trials

Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients

Clinical trial NCT02500329 · UNKNOWN

Trial details

NCT number
NCT02500329
Sponsor
Seoul National University Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Endothelial FunctionType 2 DiabetesGemigliptinAcarbose
Start date
2014-09-01
Primary completion
2015-12-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.